BIIB logo

Biogen Inc. (BIIB) Cash From Operations

Annual CFO:

$2.88B+$1.33B(+85.85%)
December 31, 2024

Summary

  • As of today, BIIB annual cash from operations is $2.88 billion, with the most recent change of +$1.33 billion (+85.85%) on December 31, 2024.
  • During the last 3 years, BIIB annual cash from operations has fallen by -$764.40 million (-21.00%).
  • BIIB annual cash from operations is now -53.53% below its all-time high of $6.19 billion, reached on December 31, 2018.

Performance

BIIB Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Quarterly CFO:

$1.27B+$1.11B(+690.86%)
September 30, 2025

Summary

  • As of today, BIIB quarterly cash from operations is $1.27 billion, with the most recent change of +$1.11 billion (+690.86%) on September 30, 2025.
  • Over the past year, BIIB quarterly cash from operations has increased by +$336.90 million (+36.01%).
  • BIIB quarterly cash from operations is now -35.21% below its all-time high of $1.96 billion, reached on June 30, 2019.

Performance

BIIB Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFO:

$2.45B+$336.90M(+15.92%)
September 30, 2025

Summary

  • As of today, BIIB TTM cash from operations is $2.45 billion, with the most recent change of +$336.90 million (+15.92%) on September 30, 2025.
  • Over the past year, BIIB TTM cash from operations has increased by +$326.50 million (+15.35%).
  • BIIB TTM cash from operations is now -65.38% below its all-time high of $7.09 billion, reached on March 31, 2020.

Performance

BIIB TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIIB Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+85.8%+36.0%+15.3%
3Y3 Years-21.0%+92.5%+2.3%
5Y5 Years-+7.7%-62.6%

BIIB Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-21.0%+107.7%at high+827.1%-14.7%+80.5%
5Y5-Year-32.0%+107.7%at high+446.6%-62.6%+80.5%
All-TimeAll-Time-53.5%>+9999.0%-35.2%+446.6%-65.4%>+9999.0%

BIIB Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.27B(+690.9%)
$2.45B(+15.9%)
Jun 2025
-
$160.90M(-37.9%)
$2.12B(-18.0%)
Mar 2025
-
$259.30M(-65.9%)
$2.58B(-10.2%)
Dec 2024
$2.88B(+85.9%)
$760.90M(-18.7%)
$2.88B(+35.2%)
Sep 2024
-
$935.60M(+49.5%)
$2.13B(+19.2%)
Jun 2024
-
$625.80M(+13.1%)
$1.78B(+8.4%)
Mar 2024
-
$553.20M(+4325.6%)
$1.65B(+6.3%)
Dec 2023
$1.55B(+11.8%)
$12.50M(-97.9%)
$1.55B(+13.8%)
Sep 2023
-
$592.40M(+21.6%)
$1.36B(-4.8%)
Jun 2023
-
$487.00M(+7.0%)
$1.43B(-14.9%)
Mar 2023
-
$455.30M(+360.2%)
$1.68B(+21.2%)
Dec 2022
$1.38B(-62.0%)
-$175.00M(-126.5%)
$1.38B(-42.3%)
Sep 2022
-
$661.00M(-10.3%)
$2.40B(-5.7%)
Jun 2022
-
$736.50M(+355.2%)
$2.54B(-16.2%)
Mar 2022
-
$161.80M(-80.7%)
$3.03B(-16.7%)
Dec 2021
$3.64B(-13.9%)
$838.30M(+4.1%)
$3.64B(+49.5%)
Sep 2021
-
$805.30M(-34.4%)
$2.43B(-13.4%)
Jun 2021
-
$1.23B(+59.6%)
$2.81B(-20.4%)
Mar 2021
-
$769.00M(+309.5%)
$3.53B(-16.5%)
Dec 2020
$4.23B(-31.6%)
-$367.10M(-131.1%)
$4.23B(-35.5%)
Sep 2020
-
$1.18B(-39.4%)
$6.56B(-7.3%)
Jun 2020
-
$1.95B(+32.8%)
$7.07B(-0.2%)
Mar 2020
-
$1.47B(-25.1%)
$7.09B(+0.1%)
Dec 2019
-
$1.96B(+15.7%)
$7.08B(+0.9%)
Sep 2019
-
$1.69B(-13.7%)
$7.01B(-0.6%)
Jun 2019
-
$1.96B(+34.6%)
$7.05B(+14.0%)
Mar 2019
-
$1.46B(-23.0%)
$6.19B(+0.0%)
Dec 2018
$6.19B(+36.0%)
$1.90B(+9.2%)
$6.19B(+6.5%)
Sep 2018
-
$1.74B(+57.9%)
$5.81B(+1.9%)
Jun 2018
-
$1.10B(-24.6%)
$5.70B(-1.2%)
Mar 2018
-
$1.46B(-4.0%)
$5.77B(+26.8%)
Dec 2017
$4.55B(+0.6%)
$1.52B(-6.8%)
$4.55B(-1.3%)
Sep 2017
-
$1.63B(+39.3%)
$4.61B(+16.2%)
Jun 2017
-
$1.17B(+397.1%)
$3.97B(+4.6%)
Mar 2017
-
$235.20M(-85.1%)
$3.79B(-17.1%)
Dec 2016
$4.52B(+21.7%)
$1.58B(+59.8%)
$4.57B(+52.6%)
Sep 2016
-
$986.60M(-0.9%)
$3.00B(+3.1%)
Jun 2016
-
$995.80M(-2.0%)
$2.91B(-1.7%)
Mar 2016
-
$1.02B(+13.4%)
$2.96B(-18.0%)
Dec 2015
$3.72B(+26.3%)
-
-
Sep 2015
-
$895.45M(-14.5%)
$3.61B(-0.5%)
Jun 2015
-
$1.05B(+42.9%)
$3.63B(+1.6%)
Mar 2015
-
$733.04M(-21.4%)
$3.57B(+21.4%)
Dec 2014
$2.94B(+25.5%)
$932.86M(+2.1%)
$2.94B(+2.2%)
Sep 2014
-
$914.03M(-7.7%)
$2.88B(+9.2%)
Jun 2014
-
$990.59M(+846.8%)
$2.64B(+16.1%)
Mar 2014
-
$104.63M(-88.0%)
$2.27B(-3.2%)
Dec 2013
$2.35B(+24.7%)
$869.00M(+29.3%)
$2.35B(+18.2%)
Sep 2013
-
$671.92M(+7.5%)
$1.98B(+7.0%)
Jun 2013
-
$625.21M(+249.4%)
$1.85B(-0.6%)
Mar 2013
-
$178.94M(-64.8%)
$1.86B(-0.8%)
Dec 2012
$1.88B(+8.8%)
$507.91M(-6.3%)
$1.88B(+1.8%)
Sep 2012
-
$541.78M(-14.8%)
$1.85B(-1.5%)
Jun 2012
-
$635.58M(+226.6%)
$1.87B(+12.3%)
Mar 2012
-
$194.63M(-58.9%)
$1.67B(-3.4%)
Dec 2011
$1.73B(+6.3%)
$473.97M(-16.9%)
$1.73B(+2.5%)
Sep 2011
-
$570.52M(+32.8%)
$1.68B(+9.2%)
Jun 2011
-
$429.67M(+69.4%)
$1.54B(+0.1%)
Mar 2011
-
$253.58M(-41.2%)
$1.54B(-5.1%)
Dec 2010
$1.62B(+51.1%)
$431.06M(+0.7%)
$1.62B(+10.1%)
Sep 2010
-
$428.24M(-0.1%)
$1.48B(+12.6%)
Jun 2010
-
$428.48M(+27.2%)
$1.31B(+18.0%)
Mar 2010
-
$336.89M(+19.4%)
$1.11B(+3.4%)
Dec 2009
$1.07B(-31.3%)
$282.17M(+7.1%)
$1.07B(-10.6%)
Sep 2009
-
$263.43M(+15.3%)
$1.20B(-17.1%)
Jun 2009
-
$228.55M(-24.0%)
$1.45B(-3.2%)
Mar 2009
-
$300.75M(-26.5%)
$1.50B(-4.2%)
Dec 2008
$1.56B(+53.3%)
$409.29M(-20.1%)
$1.56B(+4.2%)
Sep 2008
-
$512.19M(+85.6%)
$1.50B(+25.2%)
Jun 2008
-
$276.02M(-24.8%)
$1.20B(+6.6%)
Mar 2008
-
$366.99M(+6.1%)
$1.13B(+10.3%)
Dec 2007
$1.02B
$345.86M(+64.4%)
$1.02B(+11.4%)
DateAnnualQuarterlyTTM
Sep 2007
-
$210.43M(+4.2%)
$916.58M(-5.1%)
Jun 2007
-
$202.02M(-23.0%)
$965.99M(+2.0%)
Mar 2007
-
$262.33M(+8.5%)
$947.34M(+12.6%)
Dec 2006
-
$241.81M(-6.9%)
$841.27M(-3.8%)
Sep 2006
-
$259.84M(+41.7%)
$874.20M(+11.0%)
Jun 2006
-
$183.37M(+17.4%)
$787.46M(-5.5%)
Mar 2006
-
$156.25M(-43.1%)
$832.87M(-6.4%)
Dec 2005
$889.50M(+22.2%)
$274.74M(+58.7%)
$889.50M(+10.3%)
Sep 2005
-
$173.09M(-24.3%)
$806.32M(-0.7%)
Jun 2005
-
$228.78M(+7.5%)
$812.14M(+9.3%)
Mar 2005
-
$212.89M(+11.1%)
$742.91M(+2.1%)
Dec 2004
$727.99M(+232.1%)
$191.56M(+7.1%)
$727.99M(+29.3%)
Sep 2004
-
$178.91M(+12.1%)
$562.88M(+20.8%)
Jun 2004
-
$159.56M(-19.4%)
$465.93M(+36.6%)
Mar 2004
-
$197.96M(+648.3%)
$341.13M(+55.6%)
Dec 2003
$219.21M(+22.3%)
$26.45M(-67.7%)
$219.21M(-15.3%)
Sep 2003
-
$81.96M(+135.9%)
$258.76M(+11.4%)
Jun 2003
-
$34.75M(-54.3%)
$232.35M(-1.0%)
Mar 2003
-
$76.05M(+15.2%)
$234.63M(+30.9%)
Dec 2002
$179.22M(+16.5%)
$66.00M(+18.8%)
$179.22M(+9.4%)
Sep 2002
-
$55.55M(+50.0%)
$163.78M(+13.1%)
Jun 2002
-
$37.03M(+79.4%)
$144.86M(+2.2%)
Mar 2002
-
$20.64M(-59.2%)
$141.70M(-7.9%)
Dec 2001
$153.81M(+148.2%)
$50.55M(+38.0%)
$153.81M(+25.0%)
Sep 2001
-
$36.64M(+8.2%)
$123.07M(+14.8%)
Jun 2001
-
$33.87M(+3.4%)
$107.24M(+32.0%)
Mar 2001
-
$32.75M(+65.3%)
$81.25M(+31.1%)
Dec 2000
$61.98M(+18.1%)
$19.81M(-4.7%)
$61.98M(+9.6%)
Sep 2000
-
$20.80M(+163.9%)
$56.55M(+14.0%)
Jun 2000
-
$7.88M(-41.5%)
$49.60M(-14.9%)
Mar 2000
-
$13.48M(-6.3%)
$58.26M(+11.0%)
Dec 1999
$52.50M(+2003.0%)
$14.39M(+3.9%)
$52.50M(+15.5%)
Sep 1999
-
$13.85M(-16.3%)
$45.44M(+62.0%)
Jun 1999
-
$16.54M(+114.0%)
$28.05M(+47.8%)
Mar 1999
-
$7.73M(+5.5%)
$18.99M(+273.3%)
Dec 1998
-
$7.32M(+307.2%)
$5.09M(-15.2%)
Sep 1998
-
-$3.54M(-147.3%)
$6.00M(-90.0%)
Jun 1998
-
$7.47M(+221.0%)
$59.73M(-30.3%)
Mar 1998
-
-$6.17M(-175.0%)
$85.66M(-12.3%)
Dec 1997
-$2.76M(+33.4%)
$8.23M(-83.6%)
$97.63M(-31.0%)
Sep 1997
-
$50.20M(+50.3%)
$141.54M(+39.1%)
Jun 1997
-
$33.40M(+475.9%)
$101.74M(+67.0%)
Mar 1997
-
$5.80M(-88.9%)
$60.94M(+30.9%)
Dec 1996
-$4.14M(-60.0%)
$52.14M(+401.3%)
$46.54M(+840.4%)
Sep 1996
-
$10.40M(+240.5%)
$4.95M(+225.3%)
Jun 1996
-
-$7.40M(+14.0%)
-$3.95M(-8163.3%)
Mar 1996
-
-$8.60M(-181.5%)
$49.00K(-99.5%)
Dec 1995
-$2.59M(+86.5%)
$10.55M(+603.3%)
$9.45M(+224.1%)
Sep 1995
-
$1.50M(+144.1%)
-$7.61M(-2072.5%)
Jun 1995
-
-$3.40M(-525.0%)
$386.00K(-80.6%)
Mar 1995
-
$800.00K(+112.3%)
$1.99M(-94.3%)
Dec 1994
-$19.14M(-305.4%)
-$6.51M(-168.6%)
$34.89M(-29.7%)
Sep 1994
-
$9.50M(+627.8%)
$49.60M(+1.6%)
Jun 1994
-
-$1.80M(-105.3%)
$48.80M(-24.5%)
Mar 1994
-
$33.70M(+311.0%)
$64.60M(+35.7%)
Dec 1993
-$4.72M(+28.6%)
$8.20M(-5.7%)
$47.60M(-29.9%)
Sep 1993
-
$8.70M(-37.9%)
$67.90M(-3.8%)
Jun 1993
-
$14.00M(-16.2%)
$70.60M(+28.4%)
Mar 1993
-
$16.70M(-41.4%)
$55.00M(+27.6%)
Dec 1992
-$6.61M(-7.0%)
$28.50M(+150.0%)
$43.10M(+136.8%)
Sep 1992
-
$11.40M(+812.5%)
$18.20M(+203.3%)
Jun 1992
-
-$1.60M(-133.3%)
$6.00M(-25.0%)
Mar 1992
-
$4.80M(+33.3%)
$8.00M(+35.6%)
Dec 1991
-$6.17M(-157.7%)
$3.60M(+550.0%)
$5.90M(-1.7%)
Sep 1991
-
-$800.00K(-300.0%)
$6.00M(-36.2%)
Jun 1991
-
$400.00K(-85.2%)
$9.40M(-37.7%)
Mar 1991
-
$2.70M(-27.0%)
$15.10M(+41.1%)
Dec 1990
$10.70M(+242.7%)
$3.70M(+42.3%)
$10.70M(+52.9%)
Sep 1990
-
$2.60M(-57.4%)
$7.00M(+59.1%)
Jun 1990
-
$6.10M(+458.8%)
$4.40M(+358.8%)
Mar 1990
-
-$1.70M
-$1.70M
Dec 1989
-$7.50M
-
-

FAQ

  • What is Biogen Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Biogen Inc.?
  • What is Biogen Inc. annual cash from operations year-on-year change?
  • What is Biogen Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Biogen Inc.?
  • What is Biogen Inc. quarterly cash from operations year-on-year change?
  • What is Biogen Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Biogen Inc.?
  • What is Biogen Inc. TTM cash from operations year-on-year change?

What is Biogen Inc. annual cash from operations?

The current annual cash from operations of BIIB is $2.88B

What is the all-time high annual cash from operations for Biogen Inc.?

Biogen Inc. all-time high annual cash from operations is $6.19B

What is Biogen Inc. annual cash from operations year-on-year change?

Over the past year, BIIB annual cash from operations has changed by +$1.33B (+85.85%)

What is Biogen Inc. quarterly cash from operations?

The current quarterly cash from operations of BIIB is $1.27B

What is the all-time high quarterly cash from operations for Biogen Inc.?

Biogen Inc. all-time high quarterly cash from operations is $1.96B

What is Biogen Inc. quarterly cash from operations year-on-year change?

Over the past year, BIIB quarterly cash from operations has changed by +$336.90M (+36.01%)

What is Biogen Inc. TTM cash from operations?

The current TTM cash from operations of BIIB is $2.45B

What is the all-time high TTM cash from operations for Biogen Inc.?

Biogen Inc. all-time high TTM cash from operations is $7.09B

What is Biogen Inc. TTM cash from operations year-on-year change?

Over the past year, BIIB TTM cash from operations has changed by +$326.50M (+15.35%)
On this page